Humacyte Stock Price Patterns
| HUMA Stock | USD 1.00 0.02 2.06% |
Momentum 39
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.13) | EPS Estimate Current Year (0.38) | EPS Estimate Next Year (0.53) | Wall Street Target Price 7.7143 | EPS Estimate Current Quarter (0.15) |
Using Humacyte hype-based prediction, you can estimate the value of Humacyte from the perspective of Humacyte response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Humacyte using Humacyte's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Humacyte using crowd psychology based on the activity and movement of Humacyte's stock price.
Humacyte Short Interest
A significant increase or decrease in Humacyte's short interest from the previous month could be a good indicator of investor sentiment towards Humacyte. Short interest can provide insight into the potential direction of Humacyte stock and how bullish or bearish investors feel about the market overall.
200 Day MA 1.7116 | Short Percent 0.2152 | Short Ratio 6.94 | Shares Short Prior Month 36.4 M | 50 Day MA 1.1445 |
Humacyte Hype to Price Pattern
Investor biases related to Humacyte's public news can be used to forecast risks associated with an investment in Humacyte. The trend in average sentiment can be used to explain how an investor holding Humacyte can time the market purely based on public headlines and social activities around Humacyte. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Humacyte's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Humacyte.
Humacyte Implied Volatility | 2.01 |
Humacyte's implied volatility exposes the market's sentiment of Humacyte stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Humacyte's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Humacyte stock will not fluctuate a lot when Humacyte's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Humacyte to buy its stock at a price that has no basis in reality. In that case, they are not buying Humacyte because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Humacyte after-hype prediction price | USD 1.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Humacyte contract
Based on the Rule 16, the options market is currently suggesting that Humacyte will have an average daily up or down price movement of about 0.13% per day over the life of the 2026-03-20 option contract. With Humacyte trading at USD 0.99900001, that is roughly USD 0.001255 . If you think that the market is fully incorporating Humacyte's daily price movement you should consider acquiring Humacyte options at the current volatility level of 2.01%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Humacyte Basic Forecasting Models to cross-verify your projections. Humacyte After-Hype Price Density Analysis
As far as predicting the price of Humacyte at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Humacyte or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Humacyte, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Humacyte Estimiated After-Hype Price Volatility
In the context of predicting Humacyte's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Humacyte's historical news coverage. Humacyte's after-hype downside and upside margins for the prediction period are 0.05 and 5.78, respectively. We have considered Humacyte's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Humacyte is very risky at this time. Analysis and calculation of next after-hype price of Humacyte is based on 3 months time horizon.
Humacyte Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Humacyte is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Humacyte backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Humacyte, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.49 | 4.78 | 0.01 | 0.29 | 7 Events / Month | 2 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.00 | 1.00 | 0.99 |
|
Humacyte Hype Timeline
Humacyte is currently traded for 1.00. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.29. Humacyte is expected to decline in value after the next headline, with the price expected to drop to 1.0. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.99%, whereas the daily expected return is currently at -0.49%. The volatility of related hype on Humacyte is about 810.17%, with the expected price after the next announcement by competition of 1.29. About 16.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.27. Humacyte had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 7 days. Check out Humacyte Basic Forecasting Models to cross-verify your projections.Humacyte Related Hype Analysis
Having access to credible news sources related to Humacyte's direct competition is more important than ever and may enhance your ability to predict Humacyte's future price movements. Getting to know how Humacyte's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Humacyte may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NVS | Novartis AG ADR | 1.58 | 7 per month | 0.77 | 0.20 | 2.59 | (2.06) | 6.07 | |
| PFE | Pfizer Inc | 0.25 | 8 per month | 1.14 | 0.1 | 2.24 | (2.24) | 7.97 | |
| SNY | Sanofi ADR | (0.06) | 7 per month | 0.00 | (0.14) | 1.87 | (2.19) | 5.92 |
Humacyte Additional Predictive Modules
Most predictive techniques to examine Humacyte price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Humacyte using various technical indicators. When you analyze Humacyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Humacyte Predictive Indicators
The successful prediction of Humacyte stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Humacyte, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Humacyte based on analysis of Humacyte hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Humacyte's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Humacyte's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 4.52 | 2.4 | 2.76 | 2.62 | Net Debt To EBITDA | 0.24 | 0.21 | 0.25 | 0.23 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Humacyte Stock analysis
When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |